• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lipid-Producing Ciliochoroidal Melanoma with Expression of HMG-CoA Reductase.表达HMG-CoA还原酶的脂质生成性睫状体脉络膜黑色素瘤
Ocul Oncol Pathol. 2020 Dec;6(6):416-421. doi: 10.1159/000510393. Epub 2020 Oct 9.
2
The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker.葡萄膜黑色素瘤肿瘤细胞侵袭表型的特征显示存在MUC18和HMG-1转移标志物,并导致将DJ-1鉴定为一种潜在的血清生物标志物。
Int J Cancer. 2006 Sep 1;119(5):1014-22. doi: 10.1002/ijc.21942.
3
Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.抑制甲基戊二酰辅酶A还原酶II类的梅氏假单胞菌。
Protein Sci. 2004 Jun;13(6):1693-7. doi: 10.1110/ps.03597504.
4
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.HMG-CoA还原酶抑制剂的药效学与药代动力学。异同点。
Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005.
5
Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma.环缩肽在体外抑制原发性和转移性葡萄膜黑色素瘤细胞系的迁移:一种针对葡萄膜黑色素瘤的潜在策略。
Melanoma Res. 2005 Jun;15(3):147-53. doi: 10.1097/00008390-200506000-00002.
6
Effects of pravastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, on two human tumour cell lines.羟甲基戊二酰辅酶A还原酶抑制剂普伐他汀对两种人类肿瘤细胞系的作用。
J Cancer Res Clin Oncol. 1995;121(6):343-9. doi: 10.1007/BF01225686.
7
The effect of mevalonate on 3-hydroxy-3-methylglutaryl-CoA reductase activity and the absolute rate of cholesterol biosynthesis in human monocyte-derived macrophages.甲羟戊酸对人单核细胞衍生巨噬细胞中3-羟基-3-甲基戊二酰辅酶A还原酶活性及胆固醇生物合成绝对速率的影响。
Eur J Biochem. 1985 Nov 15;153(1):117-23. doi: 10.1111/j.1432-1033.1985.tb09276.x.
8
Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.甲羟戊酸对3-羟基-3-甲基戊二酰辅酶A还原酶的转录后调控
Arch Biochem Biophys. 1995 Feb 20;317(1):235-43. doi: 10.1006/abbi.1995.1158.
9
Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.植物来源的单萜在转录后水平抑制仓鼠肾细胞3-羟基-3-甲基戊二酰辅酶A还原酶的合成。
J Nutr. 2003 Jan;133(1):38-44. doi: 10.1093/jn/133.1.38.
10
Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.用美伐他汀(3-羟基-3-甲基戊二酰辅酶A还原酶的竞争性抑制剂)处理的小鼠肝脏中3-羟基-3-甲基戊二酰辅酶A还原酶的反馈调节
J Clin Invest. 1980 Nov;66(5):1094-100. doi: 10.1172/JCI109938.

引用本文的文献

1
Mitfa-Independent Melanocyte Progenitors are Highly Susceptible to GNAQ-induced Uveal Melanoma in Adult Zebrafish.Mitfa 非依赖性黑素细胞祖细胞对成年斑马鱼中 GNAQ 诱导的葡萄膜黑色素瘤高度敏感。
bioRxiv. 2025 Sep 9:2025.05.05.652300. doi: 10.1101/2025.05.05.652300.

本文引用的文献

1
Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.多模态分析提高眼窝无脉络膜黑色素瘤患者的生存预测。
Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3595-3605. doi: 10.1167/iovs.18-24818.
2
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.葡萄膜黑色素瘤的分子特征:来自癌症基因组图谱(TCGA)项目的见解
Cancers (Basel). 2019 Jul 27;11(8):1061. doi: 10.3390/cancers11081061.
3
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.658 例葡萄膜黑色素瘤患者的遗传分析,采用癌症基因组图谱分类为 A、B、C 和 D 的葡萄膜黑色素瘤。
Ophthalmology. 2019 Oct;126(10):1445-1453. doi: 10.1016/j.ophtha.2019.04.027. Epub 2019 Apr 24.
4
Mevalonate Metabolism in Cancer Stemness and Trained Immunity.甲羟戊酸代谢在癌症干性和训练免疫中的作用
Front Oncol. 2018 Sep 20;8:394. doi: 10.3389/fonc.2018.00394. eCollection 2018.
5
Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem-like cells via inhibition of the mevalonate pathway.亲脂性他汀类药物通过抑制甲羟戊酸途径,拮抗地改变乳腺癌干细胞样细胞中的主要上皮-间质转化信号通路。
J Cell Biochem. 2019 Feb;120(2):2515-2531. doi: 10.1002/jcb.27544. Epub 2018 Sep 6.
6
Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).葡萄膜黑色素瘤:发病率、治疗及生存情况的5年更新(监测、流行病学和最终结果计划,1973 - 2013年)
Ocul Oncol Pathol. 2018 Apr;4(3):145-151. doi: 10.1159/000480640. Epub 2017 Oct 13.
7
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.癌症治疗中靶向甲羟戊酸途径:他汀类药物的重新利用
Recent Pat Anticancer Drug Discov. 2018;13(2):184-200. doi: 10.2174/1574892812666171129141211.
8
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer.将甲羟戊酸途径抑制剂重新定位为卵巢癌的抗肿瘤药物。
Oncotarget. 2017 Aug 7;8(42):72147-72156. doi: 10.18632/oncotarget.20046. eCollection 2017 Sep 22.
9
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.黑色素瘤细胞的代谢策略:机制、与肿瘤微环境的相互作用及治疗意义。
Pigment Cell Melanoma Res. 2018 Jan;31(1):11-30. doi: 10.1111/pcmr.12661. Epub 2017 Nov 2.
10
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.综合分析确定了葡萄膜黑色素瘤的四个分子和临床亚组。
Cancer Cell. 2017 Aug 14;32(2):204-220.e15. doi: 10.1016/j.ccell.2017.07.003.

表达HMG-CoA还原酶的脂质生成性睫状体脉络膜黑色素瘤

Lipid-Producing Ciliochoroidal Melanoma with Expression of HMG-CoA Reductase.

作者信息

Van Ly David, Wang Duo, Conway Robert Max, Giblin Michael, Liang Sharron, Lukeis Robyn, Lim Li-Anne, Hesson Luke, Cherepanoff Svetlana

机构信息

Anatomical Pathology, SydPath, St Vincent's Hospital, Sydney, New South Wales, Australia.

School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia.

出版信息

Ocul Oncol Pathol. 2020 Dec;6(6):416-421. doi: 10.1159/000510393. Epub 2020 Oct 9.

DOI:10.1159/000510393
PMID:33447591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772867/
Abstract

Uveal melanoma (UM) is the commonest primary intraocular malignancy in adults. There is limited published data on lipid production in UM. Here, we describe the clinical, histological, immunohistochemical, and molecular findings in a ciliochoroidal melanoma with lipid production and expression of the enzyme HMG-CoA reductase. This case highlights an unusual UM tumour phenotype with a high-risk molecular metastatic profile and discusses tumour lipogenesis and activation of the mevalonate pathway as a potential therapeutic target in managing lipidised ciliochoroidal UM.

摘要

葡萄膜黑色素瘤(UM)是成人中最常见的原发性眼内恶性肿瘤。关于UM中脂质生成的已发表数据有限。在此,我们描述了一例伴有脂质生成及HMG-CoA还原酶表达的睫状体脉络膜黑色素瘤的临床、组织学、免疫组织化学和分子学发现。该病例突出了一种具有高风险分子转移特征的不寻常UM肿瘤表型,并讨论了肿瘤脂肪生成及甲羟戊酸途径的激活作为治疗脂质化睫状体脉络膜UM的潜在治疗靶点。